- Suven Life Sciences Clinical candidate SUVN-502 Being Presented at ... - PharmaLive.com (press release)
- Apollo Hospitals, Quintiles to set up Phase I Clinical Trial ... - Equity Bulls
- Suven Life Sciences spurts on bagging patens in Russia, Australia - NDTV.com
- Suven to raise funds for phase II trials of Alzheimer’s molecule - Economic Times
- Suven Life gains further on strategic alliance with VPSCRO - Myiris.com
Suven Life completes Phase I Clinical Trials Multiple Ascending ... - Equity Bulls
Suven Life completes Phase I Clinical Trials Multiple Ascending ...Equity Bulls, IndiaHyderabad, India April 9, 2009 – Suven Life Sciences Ltd, a Drug Discovery and development company announced today that it has completed its Phase 1 multiple ascending dose study of SUVN-502 in healthy volunteers. SUVN-502 is a potent, safe, ...
